Phase II study of pegylated liposomal doxorubicin in patients with metastatic malignant melanoma failing standard chemotherapy treatment (Q44400153)
Jump to navigation
Jump to search
scientific article published in April 2003
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase II study of pegylated liposomal doxorubicin in patients with metastatic malignant melanoma failing standard chemotherapy treatment |
scientific article published in April 2003 |
Statements
1 reference
Phase II study of pegylated liposomal doxorubicin in patients with metastatic malignant melanoma failing standard chemotherapy treatment (English)
1 reference
1 reference
Daniel A Vorobiof
1 reference
Rabia Mahomed
1 reference
Margaret Karime
1 reference
1 April 2003
1 reference
1 reference
13
1 reference
2
1 reference
201-203
1 reference
Identifiers
1 reference
1 reference